Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Steve Harmon who wrote (1029)	2/10/1998 12:46:00 PM
From: Cw Rohart	Respond to of 2742

>It says on the Bluestone web page that they are NASDAQ experts?<... perhaps they are experts from the "darker side"of the ...... 'DuctTape force' that keeps holding this stock back :^)....imho have fun cw

To: Steve Harmon who wrote (1029)	2/10/1998 1:29:00 PM
From: Rudy Saucillo	Read Replies (3) \| Respond to of 2742

I'm as frustrated as anyone about the lack of visible progress by BlueStone. But given the financial incentives of their contract, I find it hard to believe they're not doing something. Using your numbers, Steve, and assuming all warrants have a strike price of 25 cents, BlueStone could make a quick $1+ million if they simply sold the company for fair value. Given all CIST's cash and their lock on IL-1b, it shouldn't be hard to do. A potential $1 million windfall would certainly motivate me to get on the horn and cut a deal! It'll be interesting to see if the BlueStone contract is extended this month. Also looking forward to the periodontal longitudinal study results and the 10Q due out in a few days. Rudy